We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Mike Story Joins Scientific Advisory Board of Protein Discovery

Read time: 1 minute

Protein Discovery, Inc. has announced that Mike Story, a key figure in the development and commercialization of mass spectrometry for biological sciences, has joined the company's scientific advisory board.

Mike Story co-designed the first commercial mass spectrometry system based on quadrupole technology and was a co-founder of Finnigan Corporation, which was acquired by Thermo Electron Corp.

Among his other accomplishments, Mr. Story initiated and brought to market three major mass spectrometry technologies originating from academic institutions. 

He has detailed the requirements and specified the development of mass spectrometer-based instrumentation for analytical biochemists and molecular biologists, managed research and engineering groups, and founded, staffed, and managed distribution organizations worldwide. 

He is the author of numerous technical articles in journals and trade publications, has written two chapters of books on quadrupole mass spectrometry, and holds seven patents in the area of mass spectrometry.

Mr. Story graduated from the University of California at Berkeley with a BS degree in Chemistry and currently serves on the Board of Directors of Syagen Technology, Inc.

"Mike Story is one of the founders of the bioanalytical mass spec industry and has a long record of successful product development and commercialization in the industry. His experience is relevant to all key aspects of our business,"said Chuck Witkowski, chief executive officer of Protein Discovery.

"In addition to helping us with science and technology issues, Mike is providing sound business advice, too, as we make our transition into commercialization."

"We're fortunate to have this advisory relationship with Mike and the benefit of his counsel."

"Protein Discovery is working on valuable technologies with marketable applications in research and clinical proteomics," said new SAB member Mike Story. 

"The pharmaceutical and clinical industries are counting on the type of development breakthroughs I'm seeing at Protein Discovery to make mass spec a more practical and accessible method for routine, high-precision analysis."

Mike Story joins a distinguished roster of fellow scientists and inventors on Protein Discovery's scientific advisory board, including Richard Caprioli PhD, David Hachey PhD, Nathan Lewis PhD, Michael Sailor PhD, and Thomas Thundat PhD.